Helicobacter pylori and gastric disease

Abstract

The infection caused by Helicobacter pylori is the most common on the planet, affecting half of the global population. It is usually transmitted during childhood and persists for life if untreated. It is the primary cause of chronic gastritis, peptic ulcer, and gastric cancer. In young dyspeptic patients without alarm symptoms, the test-and-treat strategy (detection of H. pylori through a non-invasive test and subsequent eradication) is the preferred approach. The causal role of the infection in the development of gastric adenocarcinoma provides an opportunity to implement preventive strategies. The infection can be diagnosed through invasive methods (requiring endoscopy, such as the rapid urease test or histology) and non-invasive methods (such as the breath test or stool antigen test). The treatment for H. pylori combines a proton pump inhibitor with several antibiotics or bismuth salts.

Keywords: Clarithromycin; Claritromicina; Cáncer gástrico; Diagnosis; Diagnóstico; Dispepsia; Dyspepsia; Gastric cancer; Gastritis; Helicobacter pylori; Metronidazol; Metronidazole; Peptic ulcer; Tratamiento; Treatment; Úlcera péptica.